$VICR

U.S. stock index futures are muted as chipmakers pause after a rally, with oil prices falling on reports of Iran's proposal to reopen the Strait of Hormuz. Meta (META) surged +11% after its AI app gained popularity, while chip stocks like Arm (ARM) and Intel (INTC) also rose. Treasury yields fell as oil prices eased inflation concerns. Fed officials' remarks and economic data releases are in focus.

Vicor Corporation authorized a $150 million share buyback program, reflecting its financial flexibility. The company reported Q2 2026 revenue of $143.4 million, up 26.9% sequentially, with a gross profit margin of 58%. Vicor projects FY2026 revenue to exceed $600 million and expects Q3 revenue to increase nearly 10% year over year.

AutoZone shares rose 6.25% after reporting Q4 2026 results with EPS of $56.05, beating estimates, and revenue of $6.595B. MillerKnoll gained 3.35% on an earnings beat but revenue miss. Cognex fell 4.65% after announcing a $500M acquisition. Beam Global dropped 3.87% on drone acquisition plans. Zeo Energy surged 41.12% on an off-grid data center partnership.

Roth Capital reaffirmed its Buy rating on Vicor, setting a $375 price target, suggesting a 67.5% upside from the Sep 21 close. Vicor raised its Q3’26 revenue growth guidance to over 20%, citing a new non-exclusive VPD license deal with an AI OEM, which could boost revenue to $175M for the quarter.

Lennar rose 4% after Berkshire Hathaway bought 2.7M shares. Amgen gained 3% on positive trial results. Grab Holdings jumped 7% after CEO's share purchase. Capri rose 7% amid potential buyout talks. Shopify gained 7% with Meta AI integration. Quest Diagnostics and Labcorp dropped 5.3% and 3.6% on Medicare payment changes. Vicor rallied 14% on strong Q3 guidance. On Holding jumped 10% on new financial targets. GameStop gained 4% after CEO's share purchase.

Vicor (VICR) raised its Q3 revenue forecast to $172M, up over 20% sequentially, driven by AI licensing momentum. Four major OEMs and hyperscalers have licensed its Vertical Power Delivery (VPD) technology. Q2 revenue grew 26.9% to $143.4M, with royalties doubling. VICR aims for $2.5B in revenue with 70% gross margin. Shares surged over 300% year-to-date.

US futures are flat after a strong prior session, with tech and chipmakers advancing. Alibaba (BABA) rises 3% on AI chip launch. GameStop (GME) +4%, Grab (GRAB) +6%, Quest Diagnostics (DGX) -6%, Vicor (VICR) +9%, Viking Therapeutics (VKTX) +32%. Oil drops after Iran's Hormuz proposal. Treasury yields fall to 4.93%. Trump's UN address awaited.

Alibaba shares rose 3% after its CEO announced plans for 20+ gigawatts of data centers by 2032 and launched a new chip. Quest Diagnostics and Labcorp fell 5% each due to Medicare payment adjustments. Vicor gained 9% on strong Q3 guidance. On Holding jumped 6% after setting new financial targets and a $1B share buyback plan. GameStop rose 3.5% after its CEO bought 1.2M shares.

U.S. stock index futures steadied on Tuesday. Quest Diagnostics (DGX) fell 6.9% and Labcorp (LH) dropped 4.5% after CMS proposed cuts to lab reimbursements. On Holding (ONON) rose 6.4% on a $1B share buyback plan. Vicor (VICR) surged 9.9% after raising Q3 revenue outlook. Endava (DAVA) fell 12% due to CFO investigation. GameStop (GME) gained 3.5% after CEO bought shares. AnaptysBio (ANAB) rose 3.8% on better-than-expected revenue.

Needham reiterated a Buy rating on Vicor with a $320 price target, implying a 42.9% upside. Vicor raised its 3Q26 revenue guidance to over 20% growth, driven by a new AI OEM royalty agreement. The company also secured multiple licensing deals, expanding its ecosystem and monetization paths.